China Pharmaceutical (600056.SH): Pemafibrate API Approved for Marketing

date
16/11/2026
Zhitong Finance APP news, China Meheco (600056.SH) announced that recently, Tianfang Pharmaceutical Co., Ltd. ("Tianfang Pharmaceutical"), a wholly-owned subsidiary of the company, received the "Chemical API Marketing Application Approval Notice" for Pemafibrate issued by the National Medical Products Administration. On the basis of dietary control, the drug is used for adult patients with non-familial hypertriglyceridemia (HTG) to lower triglyceride (TG) levels.